Cart
sales@molnova.com
Hydroxychloroquine sulfate
CAS No. 747-36-4
Hydroxychloroquine sulfate ( HCQ; NSC 4375 )
Catalog No. M15849 CAS No. 747-36-4
Hydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 43 | In Stock |
|
| 100MG | 67 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxychloroquine sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions.
-
DescriptionHydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9.
-
SynonymsHCQ; NSC 4375
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA; TLR9
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number747-36-4
-
Formula Weight433.95
-
Molecular FormulaC18H26ClN3O·H2SO4
-
Purity>98%(HPLC)
-
SolubilityWater: 67 mg/mL (154.39 mM)
-
SMILESCCN(CCO)CCCC(NC1=CC=NC2=CC(Cl)=CC=C12)C.O=S(O)(O)=O
-
Chemical Name2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol sulfate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Koranda FC: Antimalarials. J Am Acad Dermatol. 1981 Jun;4(6):650-5.
molnova catalog
related products
-
KCC-07
KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
-
Temozolomide
An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.
-
Satraplatin
Satraplatin (BMS-182751, BMY-45594, JM-216) is a platinum-based antineoplastic agent that binds to guanine residues in DNA, inhibits DNA replication and transcription, leads to subsequent apoptosis.
